By Jennifer Ahlstrom | Posted - Jun 6th, 2016





June 25, Myeloma Crowd Round Tables on High-Risk Disease, Boston

Register Now round tableMyeloma Crowd Round Tables on High-Risk Disease are day-long meetings that provide patients and caregivers updated information so that they are able to make decisions about their treatment and care. What should myeloma patients do at relapse? Or when they become refractory to treatments? Learn from top myeloma experts about aggressive and high-risk disease and what you can do to stay one step ahead for your best outcomes. This is a great opportunity to ask your questions and meet others in the myeloma community. Topics will include:

  • Diagnosing Low and High-Risk Disease
  • Myeloma Genomics
  • Chromosomal Translocations and Plasma Cell Leukemia
  • Clinical Strategies to Prevent Smoldering Myeloma from Becoming Active
  • Sequencing Effective Combination Therapies
  • Monoclonal Antibodies and Immunotherapy
  • Vaccines and CAR T Cells

  Date: Saturday, June 25, 2016, Time: Registration begins at 7:30 am. Session runs from 8:30 am-3:30 pm Site:

  • The Colonnade Hotel, 120 Huntington Ave, Boston, MA 02116
  • If you want to book a room, call call 800-962-3030 and request the Myeloma Crowd rate of $259 per night or book online here.
  • Closest airport is Logan International Airport (BOS)

  Cost: Registration is $25 per person. (Please contact if you require additional financial assistance)   Faculty:

  • Dr. Noopur Raje, MD, PhD, Massachusetts General Hospital (Co-Host)
  • Dr. Irene Ghobrial, MD, PhD, Dana Farber Cancer Institute (Co-Host)
  • Dr. Paul Richardson, MD, Dana Farber Cancer Institute
  • Dr. David Avigan, MD, Beth Israel Deaconness Medical Center

Dr.-Raje-200x200  multiple myeloma  Dr.-Paul-Richardson  multiple myeloma Looking forward to seeing you in Boston! Thanks to our sponsors: amgenTakedaOncologyFinalSignalGeneticsLogo-COLOR

Jennifer Ahlstrom
About the Author

Jennifer Ahlstrom - Jenny A - Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical trials. Founder of Myeloma Crowd, Myeloma Crowd Radio and the CrowdCare Foundation.


Add a Comment



Thanks to our site sponsors: